Status:

UNKNOWN

Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients

Lead Sponsor:

Dermama Bioteknologi Laboratorium

Collaborating Sponsors:

Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia

Conditions:

SARS-CoV2 Infection

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

PHASE3

Brief Summary

In COVID-19 infection caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a dysregulation of the immune system response that causes cytokine storm syndrome. SARS-CoV-2...

Detailed Description

The current study is a multi-center, double arm, adjuvant, randomized control trial (RCT), double-blind clinical trial, to analyze the differences in the usefulness and safety of Exosome-MSC intraveno...

Eligibility Criteria

Inclusion

  • Diagnosed with COVID-19 pneumonia confirmed by RT-PCR examination. Samples were obtained from nasopharyngeal swabs in patients with moderate
  • There is evidence of changes in chest X-ray with a picture of COVID-19 pneumonia and/or CT-Scan of the thorax with a ground glass opacity picture
  • Willing to participate in the study and sign the informed consent by the subject or family members.

Exclusion

  • Diagnosed with mild COVID-19 pneumonia
  • Pregnant woman or positive pregnancy test
  • The subject is participating in another clinical trial.
  • Have a history of anaphylactic reactions, angioedema, or allergic reactions to antibiotics (penicillin and its derivatives) or other drugs.
  • Have an autoimmune disease
  • Have a history of malignancy
  • Undergoing hemodialysis or peritoneal dialysis
  • Recuring COVID-19 sufferers

Key Trial Info

Start Date :

July 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05216562

Start Date

July 1 2021

End Date

December 30 2022

Last Update

February 18 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

RSPAD Gatot Soebroto

Jakarta, DKI Jakarta, Indonesia, 10410

2

RSUP Dr. M. Jamil

Padang, West Sumatra, Indonesia, 25171

3

RSUP Dr. Sardjito

Yogyakarta, Indonesia, 55281